Sign in

You're signed outSign in or to get full access.

Deborah C. McLean

About Deborah C. McLean

Deborah C. McLean (born 1954) is an Independent Director of Neuberger Berman Next Generation Connectivity Fund Inc. (NBXG), serving since 2021; she has served on Neuberger Berman fund boards since 2015 and is designated an Audit Committee Financial Expert. She brings experience in private wealth management (Circle Financial Group), angel investing (Managing Director at Golden Seeds), and academic corporate finance (Adjunct Professor, Columbia SIPA since 2008). The Funds maintain a retirement policy requiring directors to retire by the end of the year in which they reach age 77.

Past Roles

OrganizationRoleTenureCommittees/Impact
Columbia University School of International and Public AffairsAdjunct Professor (Corporate Finance)Since 2008Academic finance expertise applied to fund oversight
Golden Seeds LLCManaging Director (angel investing group)Since 2009Investment screening, deal leadership and execution
Circle Financial GroupMember (private wealth management membership practice)Since 2011High-net-worth advisory perspective
Fairfield University (Dolan School of Business)Visiting Assistant ProfessorFall 2007Finance instruction
Richmond, The American International University in LondonAdjunct Associate Professor of Finance1999–2007Finance instruction
Major financial services corporation (early career)Professional training/employmentNot specifiedFoundation in financial services

External Roles

OrganizationTypeRoleSince/Until
The Maritime Aquarium at NorwalkNon-profitBoard MemberSince 2020
Norwalk Community College FoundationNon-profitBoard MemberSince 2014
Radcliffe Institute for Advanced Study (Dean’s Advisory Council)AcademicAdvisory Council Member2014–2023
At Home in DarienNon-profitDirector and Treasurer2012–2014
National Executive Service CorpsNon-profitDirector2012–2013
Richmond, The American International University in LondonAcademicTrustee1999–2013
Public company boards (current)None disclosed

Board Governance

DimensionDetail
IndependenceIndependent Director; not an “interested person” under the 1940 Act
Committees (FY2024)Audit Committee – Member; designated Audit Committee Financial Expert; committee met 7 times . Contract Review Committee – Chair; met 7 times . Executive Committee – Member; did not meet . Investment Performance Committee – Vice Chair; met 4 times .
Board LeadershipIndependent Chair structure (Chair: Tom D. Seip); Independent Chair presides, sets agendas with management, liaison role
Meetings & AttendanceEach Fund’s Board met 4 times in FY2024; each Director attended at least 75% of Board and assigned committee meetings
Annual Meeting AttendanceThe Funds do not have a policy on director attendance; none of the Board members attended the 2024 Annual Meeting
Director Compensation OversightNo standing compensation committee; Governance & Nominating Committee considers and recommends Independent Director compensation
Retirement PolicyGenerally retire by end of the year a Director reaches age 77

Fixed Compensation

ComponentAmount/TermsNotes
NBXG Aggregate Compensation (FY2024)$12,107Paid by NBXG for FY ended 10/31/2024
Total Fund Complex Compensation (CY2024)$295,000Total as trustee/director across Neuberger Berman registered investment companies
Annual Retainer (Independent Directors)$200,000 (paid quarterly)Effective Jan 1, 2024
Regular Meeting Fee$17,500 per regularly scheduled meeting attendedEffective Jan 1, 2024
Committee Chair Fee – Contract Review$35,000 per yearEffective Jan 1, 2025; applicable as Committee Chair
Committee Chair Fee – Other Committees$25,000 per yearEffective Jan 1, 2025; not applicable to Executive Committee Chair
Board Chair Premium$90,000 per year (Independent Chair)Not applicable to McLean

The Neuberger Berman funds reimburse Independent Directors for travel and related out-of-pocket expenses; compensation allocated across funds by a method the Boards find reasonable.

Performance Compensation

Performance-linked ElementMetrics/TermsStatus
Bonus/Target BonusNot applicable for directorsNo director bonus program disclosed
Equity Awards (RSUs/PSUs/Options)Not applicable for directorsNo equity compensation disclosed for directors
Performance Metrics (TSR, EBITDA, ESG, etc.)Not applicable for directorsNo performance-based pay framework disclosed

Other Directorships & Interlocks

CategoryDetail
Current Public Company DirectorshipsNone disclosed
Interlocks with Competitors/Suppliers/CustomersNone disclosed
Fund Complex OversightOversees 51 funds in the Neuberger Berman fund complex (as with other independent directors)

Expertise & Qualifications

  • Financial expert designation on Audit Committee; background spans asset management, wealth management, angel investing, and corporate finance academia.
  • Experience screening investments and leading transactions at Golden Seeds; applies investment diligence and governance acumen to fund oversight.
  • Teaching corporate finance at Columbia SIPA since 2008, providing technical grounding in valuation, capital markets, and governance topics.

Equity Ownership

HolderNBH Dollar RangeNBXG Dollar RangeAggregate Dollar Range Across Neuberger Berman Registered Investment Companies
Deborah C. McLeanNone None Over $100,000
  • Independent Directors (and immediate family) owned no securities of NBIA, its principal underwriter(s), or affiliates as of May 31, 2025.

Insider Trades

ItemDisclosure
Section 16(a) Compliance (FY2024)Based on the Funds’ review, all filing requirements were met during FY2024; one late filer noted pertained to Municipal Fund preferred-related entities, not McLean. No specific Form 4 transactions for McLean are disclosed in the proxy.

Governance Assessment

  • Strengths

    • Independent Director with Audit Committee Financial Expert designation; chairs the Contract Review Committee (key contract renewals and advisory oversight) and serves as Vice Chair of the Investment Performance Committee, signaling deep engagement on performance and oversight of adviser relationships.
    • Committee workloads are substantial (Audit met 7x; Contract Review 7x; Investment Performance 4x in FY2024), indicating active governance; McLean’s leadership roles position her centrally in risk, performance, and contract oversight.
    • No ownership or affiliations with NBIA or its principal underwriters by Independent Directors, lowering related-party conflict risk.
  • Potential Concerns / RED FLAGS

    • Ownership alignment: McLean reported “None” in NBXG shares as of May 31, 2025, which can be perceived as weaker alignment versus best practices that encourage meaningful fund-specific ownership by directors. She holds an aggregate “Over $100,000” across the fund complex, but not in NBXG specifically.
    • Shareholder engagement signal: The Funds reported no directors attended the 2024 Annual Meeting; while not required, absence may be viewed negatively by some governance-focused investors.
    • Activism context: NBXG has significant holders including Saba Capital (9.69%) and Morgan Stanley (5.4%), which can elevate governance scrutiny and expectations of director responsiveness and alignment.
  • Compensation Structure Signals

    • Director pay is cash-based: $200,000 retainer plus per-meeting fees; effective Jan 1, 2025, chair stipends were introduced/raised (Contract Review Chair $35,000), increasing compensation tied to leadership responsibilities rather than performance outcomes—neutral for alignment but highlights role-based incentives.
  • Overall View

    • McLean’s finance expertise, audit financial expert status, and leadership of the Contract Review Committee support board effectiveness. However, the absence of NBXG share ownership is a notable alignment gap that investors may monitor, especially amid concentrated activist ownership.